SAN

77.39

+2.99%↑

ARGX

727.4

+2.16%↑

SHL.DE

+2.58%↑

PHIA

22.81

+3.26%↑

FRE

37.25

+1.92%↑

SAN

77.39

+2.99%↑

ARGX

727.4

+2.16%↑

SHL.DE

+2.58%↑

PHIA

22.81

+3.26%↑

FRE

37.25

+1.92%↑

SAN

77.39

+2.99%↑

ARGX

727.4

+2.16%↑

SHL.DE

+2.58%↑

PHIA

22.81

+3.26%↑

FRE

37.25

+1.92%↑

SAN

77.39

+2.99%↑

ARGX

727.4

+2.16%↑

SHL.DE

+2.58%↑

PHIA

22.81

+3.26%↑

FRE

37.25

+1.92%↑

SAN

77.39

+2.99%↑

ARGX

727.4

+2.16%↑

SHL.DE

+2.58%↑

PHIA

22.81

+3.26%↑

FRE

37.25

+1.92%↑

Home・Aandelen Lijst・Virbac SA

Virbac SA

Open

SectorGezondheidszorg

357 4.69

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

345.5

Max

358

Belangrijke statistieken
By Trading Economics
Inkomsten	-14M 68M
Verkoop	-12M 726M
K/W Sectorgemiddelde	19.156 49.888
Dividendrendement	0.41
Winstmarge	9.427
Werknemers	6,442
EBITDA	-35M 121M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+21.7% upside

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	0.41% 2.38%

Marktinformatie
By TradingEconomics
Marktkapitalisatie	89M 2.9B
Vorige openingsprijs	352.31
Vorige sluitingsprijs	357

Nieuwssentiment

By Acuity

39%

61%

118 / 344 Rangschikking in Healthcare

Virbac SA Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

4 jun 2026, 21:51 UTC

Belangrijke Marktbewegers

Merlin Shares Rally After Defense Department's Design Review Wraps

4 jun 2026, 23:46 UTC

Marktinformatie

U.S. Jobs Data May Offer Bullish Catalyst for Dollar Vs. Yen -- Market Talk

4 jun 2026, 23:44 UTC

Marktinformatie

Nikkei May Decline Amid Middle East Uncertainty -- Market Talk

4 jun 2026, 23:42 UTC

Acquisities, Fusies, Overnames

Energy Resources of Australia: Court to Decide on Rio Tinto Compulsory Acquisition Request

4 jun 2026, 23:41 UTC

Acquisities, Fusies, Overnames

Energy Resources of Australia to Enter Trading Halt

4 jun 2026, 23:34 UTC

Marktinformatie

Oil Edges Lower Amid Mixed Middle East Developments -- Market Talk

4 jun 2026, 23:31 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

4 jun 2026, 23:31 UTC

Marktinformatie

Mercury NZ Loses Bull Despite Sector Earnings Powering Up -- Market Talk

4 jun 2026, 23:31 UTC

Marktinformatie

Global Equities Roundup: Market Talk

4 jun 2026, 23:08 UTC

Marktinformatie

Narrowing Rate Differentials Make Australian Dollar Less Attractive Versus USD -- Market Talk

4 jun 2026, 22:41 UTC

Marktinformatie

Australia Shares Set to Rise at the Open -- Market Talk

4 jun 2026, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

4 jun 2026, 20:44 UTC

Acquisities, Fusies, Overnames

RTX Stock Rises After Catching an Upgrade. Why This Analyst Is Bullish. -- Barrons.com

4 jun 2026, 20:16 UTC

Marktinformatie

Mexican Demand Indicators Show Signs of Life -- Market Talk

4 jun 2026, 20:15 UTC

Acquisities, Fusies, Overnames

Gilead Sciences And Lakefront Complete Acquisition Of Ouro Medicines To Further Expand Inflammation Pipeline >GILD

4 jun 2026, 19:46 UTC

Marktinformatie

Treasury Yields Decline Ahead of U.S. Payrolls -- Market Talk

4 jun 2026, 19:38 UTC

Marktinformatie

Oil Futures Retreat After 3-Session Winning Streak -- Market Talk

4 jun 2026, 19:30 UTC

Marktinformatie

U.S. Natural Gas Futures Rise on Weather, Storage Data -- Market Talk

4 jun 2026, 18:47 UTC

Acquisities, Fusies, Overnames

Google Stock Attracts Cathie Wood's ARK and Berkshire Hathaway. That's Rare. -- Barrons.com

4 jun 2026, 18:38 UTC

Winsten

Money Quote: Tech Weakness in Context -- WSJ

4 jun 2026, 18:24 UTC

Winsten

Quantinuum, Broadcom, UnitedHealth, and More Stocks That Explain Today's Market -- Barrons.com

4 jun 2026, 17:09 UTC

Marktinformatie

Retest of $55k Seen Possible for Bitcoin -- Market Talk

4 jun 2026, 16:58 UTC

Winsten

Broadcom, UnitedHealth, Blackstone, Ciena, and More Stocks That Explain Today's Market -- Barrons.com

4 jun 2026, 16:46 UTC

Marktinformatie

Strategy BTC Sale Continues to Weigh on Prices -- Market Talk

4 jun 2026, 16:38 UTC

Winsten

UnitedHealth Stock Rises. Why the Health Insurer Is Leading the Dow to Sharp Gains. -- Barrons.com

4 jun 2026, 16:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

4 jun 2026, 16:20 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

4 jun 2026, 16:13 UTC

Marktinformatie

On Again, Off Again Deals Keep Oil Market on Edge -- Market Talk

4 jun 2026, 16:11 UTC

Marktinformatie

Copper Market Is Awaiting Key U.S. Tariff Decision -- Market Talk

4 jun 2026, 15:56 UTC

Marktinformatie

Copper Rises Amid Hormuz Disruptions, U.S. Stockpiling -- Market Talk

Peer Vergelijking

Prijswijziging

Virbac SA Prognose

Koersdoel

By TipRanks

21.7% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 415 EUR 21.7%

Hoogste 415 EUR

Laagste 415 EUR

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Virbac SA - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Virbac SA - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

118 / 344 Rangschikking in Gezondheidszorg

Financieel

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Virbac SA

Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.